Compare TFSL & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TFSL | INDV |
|---|---|---|
| Founded | 1938 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.4B |
| IPO Year | 2006 | 2014 |
| Metric | TFSL | INDV |
|---|---|---|
| Price | $18.21 | $40.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 717.6K | ★ 1.4M |
| Earning Date | 05-12-2026 | 06-08-2026 |
| Dividend Yield | ★ 7.68% | N/A |
| EPS Growth | 14.29 | ★ 8100.00 |
| EPS | 0.16 | ★ 0.69 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $9.16 | N/A |
| Revenue Next Year | $5.22 | N/A |
| P/E Ratio | $115.47 | ★ $59.35 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $12.54 | $19.32 |
| 52 Week High | $18.53 | $42.81 |
| Indicator | TFSL | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 65.66 | 57.04 |
| Support Level | $13.21 | $38.47 |
| Resistance Level | $18.53 | $41.42 |
| Average True Range (ATR) | 0.28 | 1.30 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 86.96 | 72.78 |
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).